News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Regeneron Pharmaceuticals, Inc. Announces Participation In Panel Discussions At RBC Capital Markets Conference
December 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast discussions on two panels on which members of its senior management team will participate at the RBC Capital Conference on December 14, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Events
Regeneron Pharmaceuticals, Inc.
MORE ON THIS TOPIC
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
·
6 min read
·
Heather McKenzie
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
January 14, 2026
·
4 min read
·
Tristan Manalac
obesity
JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
January 13, 2026
·
3 min read
·
Annalee Armstrong